Related references
Note: Only part of the references are listed.Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target
Khanyisani Ziqubu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
The Effect of Orlistat on Sterol Metabolism in Obese Patients
Yu-Jin Kwon et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Cellular and Molecular Mechanisms of Metformin Action
Traci E. LaMoia et al.
ENDOCRINE REVIEWS (2021)
Adipokines as a therapeutic target by metformin to improve metabolic function: A systematic review of randomized controlled trials
Phiwayinkosi Dludla et al.
PHARMACOLOGICAL RESEARCH (2021)
Anti-Atherogenic Effects of Orlistat on Obesity-Induced Vascular Oxidative Stress Rat Model
Zaidatul Akmal Othman et al.
ANTIOXIDANTS (2021)
Metal Complex Formation and Anticancer Activity of Cu(I) and Cu(II) Complexes with Metformin
Sherin Abdelrahman et al.
MOLECULES (2021)
Undercover Toxic Menage a Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells
Terenzio Congiu et al.
PHARMACEUTICS (2021)
Metformin: current clinical applications in nondiabetic patients with cancer
Kailin Chen et al.
AGING-US (2020)
The impact of metformin and aspirin on T -cell mediated inflammation: A systematic review of in vitro and in vivo findings
Tawanda Maurice Nyambuya et al.
LIFE SCIENCES (2020)
Obesity-induced testicular oxidative stress, inflammation and apoptosis: Protective and therapeutic effects of orlistat
Joseph Bagi Suleiman et al.
REPRODUCTIVE TOXICOLOGY (2020)
Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice
Iara Karise et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota
Aneseh Adeshirlarijaney et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
Effects of metformin on metabolism of white and brown adipose tissue in obese C57BL/6J mice
Tao Yuan et al.
DIABETOLOGY & METABOLIC SYNDROME (2019)
Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study)
Alper Sonmez et al.
OBESITY FACTS (2019)
Understanding the impact of commonly utilized, non-insulin, glucose-lowering drugs on body weight in patients with type 2 diabetes
Kathryn M. Hurren et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db mice
Sebastian Steven et al.
CARDIOVASCULAR RESEARCH (2018)
Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes
Tongzhi Wu et al.
DIABETES OBESITY & METABOLISM (2017)
Excessive intake of trans fatty acid accelerates atherosclerosis through promoting inflammation and oxidative stress in a mouse model of hyperlipidemia
Tomoko Monguchi et al.
JOURNAL OF CARDIOLOGY (2017)
Health Effects of Overweight and Obesity in 195 Countries
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes
Siwei Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
The Relationship Between Glycemic Variability and Inflammatory Markers in Obese Children with Insulin Resistance and Metabolic Syndrome
Abdurrahman Kaya et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2017)
Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells
Xin Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial
L. Masmiquel et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Metformin Prevents Fatty Liver and Improves Balance of White/Brown Adipose in an Obesity Mouse Model by Inducing FGF21
Eun Kyung Kim et al.
MEDIATORS OF INFLAMMATION (2016)
Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes
David C.W. Lau et al.
Canadian Journal of Diabetes (2015)
The effects of anti-obesity intervention with orlistat and sibutramine on microvascular endothelial function
Belqes Abdullah Mohammad Al-Tahami et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2015)
Drugs Commonly Associated With Weight Change: A Systematic Review and Meta-analysis
Juan Pablo Domecq et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
N. M. Aldekhail et al.
OBESITY REVIEWS (2015)
Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: Focus on sample preparation and derivatization conditions
Daniela Weber et al.
REDOX BIOLOGY (2015)
Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations
J. H-E. Kang et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes
G. Derosa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity
Pathmaja Paramsothy et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Relation Between Obesity and the Attainment of Optimal Blood Pressure and Lipid Targets in High Vascular Risk Outpatients
Vineet Bhan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
In Vitro Interactions of Extracellular Histones with LDL Suggest a Potential Pro-Atherogenic Role
Alan D. Pemberton et al.
PLOS ONE (2010)
ACAT Inhibition and Progression of Carotid Atherosclerosis in Patients With Familial Hypercholesterolemia The CAPTIVATE Randomized Trial
Marijn C. Meuwese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Cardiac energy metabolism in obesity
Gary D. Lopaschuk et al.
CIRCULATION RESEARCH (2007)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Effect of orlistat on cardiovascular disease risk in obese adults
BA Swinburn et al.
DIABETES OBESITY & METABOLISM (2005)
Protective effect of a lignan-containing flaxseed extract against CCl4-induced hepatic injury
D Endoh et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2002)
Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics
PP Simonen et al.
OBESITY RESEARCH (2002)
Share Paper
